4H2-30872-94816
4 vaccinations
3 coded responses
26 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 101 / NY
- Registered
- 2021-01-01
- Relationship
- Self
- Race
- Other
- Ethnicity
- Hispanic or Latino
Timeline
-
2020-12-31
Dose 1 — Pfizer-BioNTech
-
2021-01-01
Registered in v-safe
-
2021-01-01
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-02
- 2021-01-03
- 2021-01-05
- 2021-01-06
- 2021-01-07
- 2021-01-17
-
2021-01-21
Dose 2 — Pfizer-BioNTech
- 2021-02-22
- 2021-02-25
- 2021-03-04
- 2021-04-23
- 2021-07-23
-
2021-12-17
Dose 3 — Pfizer-BioNTech
- 2022-01-21
- 2022-01-21
- 2022-01-28
- 2022-03-18
-
2022-06-16
Dose 4 — Pfizer-BioNTech
- 2022-06-18
- 2022-06-23
- 2022-07-03
- 2022-07-07
- 2022-07-14
- 2022-07-21
- 2022-07-28
-
2022-09-17
Survey response — 3 months, dose 4MedDRA: Oropharyngeal pain — Feeling: PoorFree text: Sore throat twice (one presently)MedDRA releases: 2024-11 · check-in free text available
-
2022-12-15
Survey response — 6 months, dose 4MedDRA: Influenza like illness, Influenza virus test negative, Nasopharyngitis, SARS-CoV-2 test negative — Feeling: Good · Be unable to do your normal daily activitiesFree text: Flu & cold like symptoms (negative flu & COVID)MedDRA releases: 2024-11 · check-in free text available
-
2023-06-16
Survey response — 12 months, dose 4MedDRA: Hand-foot-and-mouth disease — Feeling: Good · Be unable to work or attend schoolMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-31 | Pfizer-BioNTech | |
| 2 | 2021-01-21 | Pfizer-BioNTech | |
| 3 | 2021-12-17 | Pfizer-BioNTech | No |
| 4 | 2022-06-16 | Pfizer-BioNTech | No |
Free text
Release 12 — 3 months, dose 4
Symptoms: Sore throat twice (one presently)
Release 12 — 6 months, dose 4
Symptoms: Flu & cold like symptoms (negative flu & COVID)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Hand-foot-and-mouth disease | · | · | ✓ |
| SD | Influenza like illness | · | · | ✓ |
| SD | Influenza virus test negative | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release